Charles McNerney
Director/Board Member at HAPBEE TECHNOLOGIES, INC.
Net worth: - $ as of 30/04/2024
Profile
Charles E.
McNerney is an Independent Director at EMulate Therapeutics, Inc. and Hapbee Technologies, Inc. He was the Chief Information Security Officer at Microsoft Corp.
from 1993 to 2019 and the Chief Information Security Officer & VP at Expedia Group, Inc. from 2019 to 2022.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
28/10/2022 | 0 ( -.--% ) | - $ | 30/04/2024 |
Charles McNerney active positions
Companies | Position | Start |
---|---|---|
HAPBEE TECHNOLOGIES, INC. | Director/Board Member | 22/05/2019 |
EMulate Therapeutics, Inc.
EMulate Therapeutics, Inc. Medical SpecialtiesHealth Technology EMulate Therapeutics, Inc. is a clinical-stage therapeutic device company, which engages in the business of developing noninvasive therapies for cancers and other serious diseases. The firm is also involved in developing treatments for multiple disease areas that affect human health. The company was founded by Bennett Mike Butters and John Kingma on February 7, 2002 and is headquartered in Bellevue, WA. | Director/Board Member | 01/01/2016 |
Former positions of Charles McNerney
Companies | Position | End |
---|---|---|
EXPEDIA GROUP, INC. | Corporate Officer/Principal | 01/03/2022 |
MICROSOFT CORPORATION | Corporate Officer/Principal | 01/11/2019 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
HAPBEE TECHNOLOGIES, INC. | Electronic Technology |
EXPEDIA GROUP, INC. | Consumer Services |
MICROSOFT CORPORATION | Technology Services |
Private companies | 1 |
---|---|
EMulate Therapeutics, Inc.
EMulate Therapeutics, Inc. Medical SpecialtiesHealth Technology EMulate Therapeutics, Inc. is a clinical-stage therapeutic device company, which engages in the business of developing noninvasive therapies for cancers and other serious diseases. The firm is also involved in developing treatments for multiple disease areas that affect human health. The company was founded by Bennett Mike Butters and John Kingma on February 7, 2002 and is headquartered in Bellevue, WA. | Health Technology |
- Stock Market
- Insiders
- Charles McNerney